OKTORX Trademark

Trademark Overview

On Thursday, May 29, 2025, a trademark application was filed for OKTORX with the United States Patent and Trademark Office. The USPTO has given the OKTORX trademark a serial number of 99207467. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 3, 2026. This trademark is owned by OKtoRX incorporated. The OKTORX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information in the field of prescription safety and medication management, namely, AI driven drug interaction and prescription safety information, to patients and healthcare professionals via a website
oktorx

General Information

Serial Number99207467
Word MarkOKTORX
Filing DateThursday, May 29, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2026

Trademark Statements

Pseudo MarkOK TO RX; OKAY TO PRESCRIPTION
Goods and ServicesProviding medical information in the field of prescription safety and medication management, namely, AI driven drug interaction and prescription safety information, to patients and healthcare professionals via a website

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 29, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOKtoRX incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, DE 19901
US
Party NameOKtoRX incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19901
US

Trademark Events

Event DateEvent Description
Thursday, May 29, 2025NEW APPLICATION ENTERED
Thursday, May 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 29, 2025APPLICATION FILING RECEIPT MAILED
Thursday, October 16, 2025ASSIGNED TO EXAMINER
Thursday, October 23, 2025NON-FINAL ACTION WRITTEN
Thursday, October 23, 2025NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 27, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 27, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 19, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 19, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 19, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 19, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 19, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 19, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 19, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 5, 2026EXAMINERS AMENDMENT -WRITTEN
Thursday, February 5, 2026EXAMINERS AMENDMENT E-MAILED
Thursday, February 5, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 5, 2026EXAMINER'S AMENDMENT ENTERED
Thursday, February 5, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 25, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 3, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 3, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

oktorx safety information prescription patients interaction healthcare website drug professionals management